Header Logo

Connection

Vignesh Arasu to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Vignesh Arasu has written about Breast Neoplasms.
Vignesh Arasu
Connection Strength
2.359
Breast Neoplasms
  1. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
    View in: PubMed
    Score: 0.496
  2. Response. Radiology. 2013 Feb; 266(2):685-6.
    View in: PubMed
    Score: 0.243
  3. Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology. 2012 Aug; 264(2):371-7.
    View in: PubMed
    Score: 0.232
  4. Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Acad Radiol. 2011 Jun; 18(6):716-21.
    View in: PubMed
    Score: 0.213
  5. Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women. Breast Cancer Res. 2023 08 06; 25(1):92.
    View in: PubMed
    Score: 0.126
  6. Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic. Perm J. 2022 06 29; 26(2):54-63.
    View in: PubMed
    Score: 0.116
  7. Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective. Ann Surg Oncol. 2021 Oct; 28(10):5648-5656.
    View in: PubMed
    Score: 0.110
  8. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
    View in: PubMed
    Score: 0.110
  9. Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial. Tomography. 2020 06; 6(2):77-85.
    View in: PubMed
    Score: 0.101
  10. Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy. Tomography. 2020 06; 6(2):101-110.
    View in: PubMed
    Score: 0.101
  11. Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer. Tomography. 2020 06; 6(2):216-222.
    View in: PubMed
    Score: 0.101
  12. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL. J Magn Reson Imaging. 2019 12; 50(6):1742-1753.
    View in: PubMed
    Score: 0.093
  13. Sonographic-MRI Correlation After Percutaneous Sampling of Targeted Breast Ultrasound Lesions: Initial Experiences With Limited-Sequence Unenhanced MRI for Postprocedural Clip Localization. AJR Am J Roentgenol. 2018 Apr; 210(4):927-934.
    View in: PubMed
    Score: 0.086
  14. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices. Radiology. 2018 03; 286(3):822-829.
    View in: PubMed
    Score: 0.084
  15. Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists. Acad Radiol. 2017 01; 24(1):60-66.
    View in: PubMed
    Score: 0.079
  16. Lesion morphology on breast MRI affects targeted ultrasound correlation rate. Eur Radiol. 2015 May; 25(5):1279-84.
    View in: PubMed
    Score: 0.069

© 2025 Kaiser Permanente